Moneycontrol
Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Nine Months - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 17, 14:49
2371.35
23.4 (1%)
VOLUME 95,219
LIVE
NSE
Aug 17, 14:49
2370.00
16.55 (0.7%)
VOLUME 762,800
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Nine Months of Dr Reddys Laboratories

------------------- in Rs. Cr. -------------------
Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
Net Sales/Income from operations 6,826.00 7,324.70 7,867.00 7,256.17 7,051.60
Other Operating Income 41.00 35.00 46.50 66.05 61.33
Total Income From Operations 6,867.00 7,359.70 7,913.50 7,322.22 7,112.93
EXPENDITURE
Consumption of Raw Materials 1,437.00 1,434.60 1,560.90 1,850.62 1,619.63
Purchase of Traded Goods 457.00 502.90 483.70 394.85 335.81
Increase/Decrease in Stocks -12.70 -167.20 -74.90 -159.03 -101.92
Power & Fuel -- -- -- -- --
Employees Cost 1,379.70 1,431.00 1,261.20 1,106.53 890.63
Depreciation 584.10 545.50 468.30 353.46 281.55
Excise Duty -- -- -- -- --
Admin. And Selling Expenses 800.70 759.70 771.70 840.12 621.38
R & D Expenses -- -- -- -- 607.21
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 1,801.80 1,963.90 1,877.90 1,665.75 1,044.77
P/L Before Other Inc. , Int., Excpt. Items & Tax 419.40 889.30 1,564.70 1,269.92 1,813.87
Other Income 130.90 533.20 226.30 147.11 102.71
P/L Before Int., Excpt. Items & Tax 550.30 1,422.50 1,791.00 1,417.03 1,916.58
Interest 48.70 41.40 49.50 45.03 59.33
P/L Before Exceptional Items & Tax 501.60 1,381.10 1,741.50 1,372.00 1,857.25
Exceptional Items -- -- -- -- --
P/L Before Tax 501.60 1,381.10 1,741.50 1,372.00 1,857.25
Tax 111.30 220.00 328.50 264.07 395.84
P/L After Tax from Ordinary Activities 390.30 1,161.10 1,413.00 1,107.93 1,461.41
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 390.30 1,161.10 1,413.00 1,107.93 1,461.41
Equity Share Capital 82.90 82.90 85.30 85.18 85.05
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 23.54 69.55 82.86 65.06 85.95
Diluted EPS 23.49 69.38 82.60 64.77 85.53
EPS After Extra Ordinary
Basic EPS 23.54 69.55 82.86 65.06 85.95
Diluted EPS 23.49 69.38 82.60 64.77 85.53
Public Share Holding
No Of Shares (Crores) -- -- -- 9.73 9.76
Share Holding (%) -- -- -- 57.11 57.37
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- 4.34 4.34
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- 25.49 25.53
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for drreddyslaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.